Suppr超能文献

高龄原发性甲状腺淋巴瘤的快速通道管理。

Fast Track Management of Primary Thyroid Lymphoma in the Very Elderly Patient.

机构信息

Radiodiagnostics and Interventional Radiology Department, Polyclinics ELSAN Medipole Sud, Quartier Quiez, 83189 Ollioules, France.

Department of Hematology, Centre Hospitalier de la côte Basque, College of Health Sciences, Bordeaux University, 64100 Bayonne, France.

出版信息

Curr Oncol. 2023 Jun 15;30(6):5816-5827. doi: 10.3390/curroncol30060435.

Abstract

A rapid growing cervical mass mobile while swallowing is the most common clinical presentation of severe thyroid malignancy. A 91-year-old female patient with a history of Hashimoto thyroiditis presented with clinical compressive neck symptoms. The patient had gastric Maltoma diagnosed that was surgically resected thirty years ago. A straightforward process was needed to reach full histological diagnosis and initiate prompt therapy. Ultrasound (US) showed a 67 mm hypoechoic left thyroid mass with reticulated pattern without signs of locoregional invasion. Percutaneous trans isthmic US-guided 18G core needle biopsy (CNB) disclosed diffuse large B cell lymphoma of the thyroid gland. FDG PET revealed two distinct thyroid and gastric foci (both SUVmax 39.1). Therapy was initiated rapidly to decrease clinical symptoms in this aggressive stage III primitive malignant thyroid lymphoma. The prognostic nomogram was calculated by using a seven-item scale, which disclosed a one-year overall survival rate of 52%. The patient underwent three R-CVP chemotherapy courses, then refused further treatment and died within five months. Real-time US-guided CNB approach led to rapid patient's management that was tailored to patient's characteristics. Transformation of Maltoma into diffuse large B cell lymphoma (DLBCL) into two body areas is deemed to be extremely rare.

摘要

吞咽时可移动的快速生长的颈肿块是严重甲状腺恶性肿瘤最常见的临床表现。一位 91 岁的女性患者有桥本甲状腺炎病史,表现为临床压迫性颈部症状。患者 30 年前曾被诊断为胃黏膜相关淋巴瘤,并接受了手术切除。为了获得完整的组织学诊断并及时开始治疗,需要一个直接的过程。超声(US)显示左侧甲状腺有一个 67mm 的低回声肿块,呈网状图案,无局部侵犯迹象。经皮经峡部 US 引导 18G 核心针活检(CNB)显示甲状腺弥漫性大 B 细胞淋巴瘤。FDG PET 显示两个不同的甲状腺和胃病灶(均 SUVmax 为 39.1)。为了降低该侵袭性 III 期原始恶性甲状腺淋巴瘤患者的临床症状,迅速开始了治疗。通过使用七项评分计算了预后列线图,显示一年总生存率为 52%。患者接受了三个 R-CVP 化疗疗程,然后拒绝进一步治疗,在五个月内死亡。实时 US 引导 CNB 方法可快速管理患者,针对患者的特点进行个体化治疗。从黏膜相关淋巴瘤(MALToma)转化为弥漫性大 B 细胞淋巴瘤(DLBCL),并在两个身体部位出现,这种情况被认为极为罕见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d748/10297318/84a3b0cf191f/curroncol-30-00435-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验